Back to Search
Start Over
HR+ HER2-ve Breast Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
- Source :
- M2 Presswire. November 5, 2024
- Publication Year :
- 2024
-
Abstract
- M2 PRESSWIRE-November 5, 2024-: HR+ HER2-ve Breast Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers (C)1994-2024 M2 COMMUNICATIONS RDATE:04112024 DelveInsight's, 'HR Positive/ HER2 Negative Breast Cancer [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.814830593